Latest data shows the largest indicative borrow rate increases among liquid option names include: Ambrx Biopharma (AMAM) 27.55% +6.02, Chindata Group (CD) 64.17% +4.66, Novavax (NVAX) 98.89% +3.45, BioXcel Therapeutics (BTAI) 25.86% +2.68, BrainStorm (BCLI) 28.49% +2.28, Powershares Loan ETF (BKLN) 11.08% +1.32, Invitae (NVTA) 25.13% +1.30, CAVA Group Inc (CAVA) 24.63% +1.18, ImmunityBio (IBRX) 94.84% +0.84, and Nano X (NNOX) 9.96% +0.68.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on AMAM:
- Cantor biotech/biopharma analysts hold an analyst/industry conference call
- Ambrx Biopharma price target raised to $33 from $29 at RBC Capital
- Ambrx Biopharma announces data from Phase 1/2 APEX-01 study of ARX517
- Ambrx Biopharma files $300M mixed securities shelf
- Ambrx Biopharma trading resumes
Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.
Report an Issue